ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.
Headquartered in Barranquilla, Colombia, Rocol provides products, services, and medical equipment in the fields of ophthalmology, dermatology, aesthetics, oncology and robotics for the entire Latin American market.
"Rocol is a well-respected and recognized leader in the commercialization of medical equipment in ophthalmology and aesthetics across Latin America," said Robert E. Grant, CEO of ALPHAEON. "This acquisition enables ALPHAEON to expand its presence in these key emerging markets."
"We believe ALPHAEON's social commerce platform, practice management suite and broad product portfolio will allow us to offer greater value to our customers," said Roberto Garcia, President of Rocol. "Together we believe we have a tremendous opportunity to drive the business forward utilizing ALPHAEON's digital platform and our market expertise."
Enhancing the adoption of pragmatic clinical trial results in healthcare systems